Open AccessUtility of weekly docetaxel combined with preoperative radiotherapy for locally advanced esophageal cancer from pathological analysis
Author(s) -
Kushida T.,
Nohara S.,
Yoshino K.,
Fujiwara D.,
Ouchi K.,
Amano T.,
Isayama F.,
Tomita N.,
Iwanuma Y.,
Sasai K.,
Tsurumaru M.,
Kajiyama Y.
Publication year - 2013
Publication title -
diseases of the esophagus
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.115
H-Index - 63
eISSN - 1442-2050
pISSN - 1120-8694
DOI - 10.1111/dote.12105
Subject(s) - medicine , docetaxel , esophageal cancer , oncology , chemoradiotherapy , radiation therapy , hazard ratio , esophagectomy , stage (stratigraphy) , regimen , neoadjuvant therapy , surgery , cancer , confidence interval , paleontology , biology , breast cancer
Summary Esophageal squamous cell cancer ( ESCC ) is a high‐grade carcinoma that is treated with multidisciplinary approaches, including chemoradiotherapy ( CRT ) followed by surgery. Despite some success with these therapies, overall survival remains poor. In order to investigate a newer CRT regimen, we designed a comparative study to evaluate preoperative CRT using docetaxel ( DOC ) or 5‐ F luorouracil and cisplatin ( FU + CDDP [ FP ] therapy) for treatment of resectable ESCC . In a retrospective review of patients with resectable, locally advanced ESCC , 95 patients received preoperative CRT between 2001 and 2007. CRT was administered using either FP ( n = 40) or DOC ( n = 55). Pathological response and clinical outcomes were compared between the two groups. Hazard ratios and time‐to‐event analyses were used to assess outcomes; the ratios were controlled by multivariate logistic regression analysis of potential prognostic factors, and survival was presented with K aplan– M eier curves. In the FP group, a significant curative effect was observed on the basis of pathological examination of postoperative lesions. However, the DOC group presented a significantly better prognosis on the basis of cumulative survival rates. Logistic regression analysis revealed that the presence of five or more lymph node metastases was an independent predictor of reduced survival. Patients with lymph node metastasis exhibited a better prognosis in the DOC group than those in the FP group. Preoperative CRT for locally advanced esophageal cancer using DOC results in similar or better long‐term outcomes compared with FP ‐based CRT . Therefore, CRT using DOC is a promising therapy option for esophageal cancer.